HS-10502 Combination Treatment in Patients With Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Recurrent Ovarian Cancer · HER2-negative · Advanced Breast Cancer · TNBC · Advanced Prostate Cancer · Advanced Gastric Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Ding Wei Ye) · fuscc2012@163.com · 13701663571

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Refractory Cancer · Recurrent Cancer · Solid Tumor, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Stanford, United States · Aurora, United States

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Metastatic Solid Tumor · Recurrent Solid Tumor · Advanced Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · La Jolla, United States

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Breast Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Aurora, United States · Aurora, United States

Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy

Ovarian Cancer · Ovarian Carcinoma, Recurrent · Ovarian Cancer Metastatic Recurrent

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea